Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium 1%Awİw + Linseed Oil 3%w/w + Methyl Salicylate 10%w/w + Menthol 59iw/w + thiocolchicoside 0.125%w/w + Benzyl Alcohol 1%w/W'

Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium 1%Awİw + Linseed Oil 3%w/w + Methyl Salicylate 10%w/w + Menthol 59iw/w + thiocolchicoside 0.125%w/w + Benzyl Alcohol 1%w/W' is a topical formulation formulated with Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium 1%Awİw + Linseed Oil 3%w/w + Methyl Salicylate 10%w/w + Menthol 59iw/w + thiocolchicoside 0.125%w/w + Benzyl Alcohol 1%w/W'. The listed active ingredient profile is Diclofenac Diethylamine w/w . Diclofenac sodium Awİw; Linseed Oil w/w; Methyl Salicylate w/w; Menthol 59iw/w; thiocolchicoside w/w; Benzyl Alcohol w/W', placing the product in the topical analgesic / musculoskeletal category. The formulation contains topical analgesic/counter-irritant ingredients intended for localized musculoskeletal pain relief where appropriate. The dosage form is intended for topical/local application; the exact application site and frequency must follow the approved product instructions. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.